136 related articles for article (PubMed ID: 38413077)
1. [Interpretation of Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction(2024 edition)].
Liu K; Zhu YF; Yang YS; Chen LQ; Hu JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Feb; 27(2):127-131. PubMed ID: 38413077
[TBL] [Abstract][Full Text] [Related]
2. [Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (Edition 2024)].
; ; ; ;
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Feb; 27(2):109-126. PubMed ID: 38413076
[TBL] [Abstract][Full Text] [Related]
3. [Interpretation of Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (2018 edition)].
Yuan Y; Chen X; Hu J; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):101-106. PubMed ID: 30799531
[TBL] [Abstract][Full Text] [Related]
4. [Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (2018 edition)].
Chen L; Hu J; Ji J; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):961-975. PubMed ID: 30269314
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of Siewert type II adenocarcinoma of the esophagogastric junction: the perspectives from thoracic surgery].
Li ZY; Gu YM; Wang WP; Chen LQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):109-113. PubMed ID: 35176820
[TBL] [Abstract][Full Text] [Related]
6. [Retrospect of 2019: focus on the surgical treatment for adenocarcinoma of esophagogastric junction].
Yan CY; Chen LQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):20-25. PubMed ID: 31958926
[TBL] [Abstract][Full Text] [Related]
7. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
8. [Current status and progression of minimally invasive surgery after neoadjuvant therapy for adenocarcinoma of esophagogastric junction].
Zhao EH; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):141-146. PubMed ID: 35176826
[TBL] [Abstract][Full Text] [Related]
9. [Laparoscopic proximal gastrectomy and lymph node resection in adenocarcinoma of the esophagogastric junction].
Zhao JJ; Liu FL
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):114-119. PubMed ID: 35176821
[TBL] [Abstract][Full Text] [Related]
10. [To improve the cognition about the carcinoma of esophagogastric junction].
Xue YW; Yu XF
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):125-7. PubMed ID: 23446469
[TBL] [Abstract][Full Text] [Related]
11. [Dilemmas in definition and classification of adenocarcinoma of esophagogastric junction: from history to current status].
Chen L; Liu FL
Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):813-818. PubMed ID: 36058706
[TBL] [Abstract][Full Text] [Related]
12. [Standardized implementation of minimally invasive surgery for Siewert Ⅱ esophagogastric junction adenocarcinoma].
Zhu JM; Wang X; Gao ZM; Wang ZN
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):104-108. PubMed ID: 35176819
[TBL] [Abstract][Full Text] [Related]
13. [Surgical strategy for adenocarcinoma of esophagogastric junction].
Lu Y; Zhang K; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532
[TBL] [Abstract][Full Text] [Related]
14. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
15. Treatment of esophagogastric junction carcinoma: an unsolved debate.
Orditura M; Galizia G; Lieto E; De Vita F; Ciardiello F
World J Gastroenterol; 2015 Apr; 21(15):4427-31. PubMed ID: 25914451
[TBL] [Abstract][Full Text] [Related]
16. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
[TBL] [Abstract][Full Text] [Related]
17. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction.
Reynolds JV; Ravi N; Muldoon C; Larkin JO; Rowley S; O'Byrne K; Hollywood D; O'Toole D
World J Surg; 2010 Dec; 34(12):2821-9. PubMed ID: 20827475
[TBL] [Abstract][Full Text] [Related]
18. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
[TBL] [Abstract][Full Text] [Related]
19. Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor.
Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Shigaki H; Yamaguchi T
Ann Surg Oncol; 2014 May; 21(5):1596-601. PubMed ID: 24531703
[TBL] [Abstract][Full Text] [Related]
20. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus.
Moehler M; Baltin CT; Ebert M; Fischbach W; Gockel I; Grenacher L; Hölscher AH; Lordick F; Malfertheiner P; Messmann H; Meyer HJ; Palmqvist A; Röcken C; Schuhmacher C; Stahl M; Stuschke M; Vieth M; Wittekind C; Wagner D; Mönig SP
Gastric Cancer; 2015 Jul; 18(3):550-63. PubMed ID: 25192931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
